Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)

CNY 9.07

(3.66%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.95 Billion 2.31 Billion 1.83 Billion 1.38 Billion 886.14 Million 801.97 Million
Total Current Assets 1.67 Billion 1.13 Billion 1.02 Billion 979.92 Million 601.62 Million 536.11 Million
Cash And Short Term Investments 1.12 Billion 612.87 Million 674.55 Million 739.1 Million 342.08 Million 278.89 Million
Cash and Cash Equivalents 1.12 Billion 608.85 Million 564.55 Million 739.1 Million 341.54 Million 278.03 Million
Short Term Investments - 4.01 Million 110 Million - 542.45 Thousand 857.79 Thousand
Net Receivables 181.51 Million 147.11 Million 72.62 Million 47.71 Million 66.4 Million 80.62 Million
Inventory 365.17 Million 320.56 Million 243.44 Million 190.16 Million 187.94 Million 129.18 Million
Other Current Assets 3.79 Million 56.14 Million 29.96 Million 2.93 Million 5.19 Million 47.41 Million
Total Non-Current Assets 1.27 Billion 1.17 Billion 818.87 Million 401.76 Million 284.51 Million 265.85 Million
Net PPE 1.05 Billion 950.94 Million 601.45 Million 299.91 Million 245.81 Million 227.55 Million
Good Will And Intangible Assets 150.36 Million 153.94 Million 156.16 Million 59.3 Million 35.22 Million 35.71 Million
Good Will - - - - - -
Intangible Assets 150.36 Million 153.94 Million 156.16 Million 59.3 Million 35.22 Million 35.71 Million
Long-Term Investments 67.36 Million 46.12 Million -77.35 Million 13.07 Million 1.00 -
Tax Assets 2.00 6.86 Million 4.47 Million 4.71 Million 3.48 Million 2.59 Million
Other Non Current Assets 8.46 Million 20.74 Million 134.13 Million 24.74 Million - 2.00
Other Assets 1.00 1.00 - - 1.00 -
Total Liabilities 809.99 Million 854.18 Million 584.64 Million 254.8 Million 240.95 Million 204.37 Million
Total Current Liabilities 770.96 Million 745.42 Million 530.32 Million 243.87 Million 232.14 Million 196.51 Million
Account Payables 301.09 Million 519.32 Million 402.24 Million 171.25 Million 170.47 Million 109.61 Million
Tax Payables 10.21 Million 3.82 Million 9.01 Million 4.24 Million 135.39 Thousand 308.3 Thousand
Short Term Debt 410.88 Million 169.27 Million 65.07 Million 41.04 Million 44.95 Million 72 Million
Deferred Revenue 7.05 Million 12.62 Million 62.41 Million 31.56 Million 15.01 Million 308.3 Thousand
Other Current Liabilities 51.93 Million 44.19 Million 586.84 Thousand 4603.00 1.69 Million 14.59 Million
Total Non Current Liabilities 39.02 Million 108.76 Million 54.31 Million 10.93 Million 8.81 Million 7.86 Million
Long-Term Debt 2.03 Million 72.74 Million 44.85 Million - - 1.00
Deferred Revenue Non Current 34.91 Million 23.5 Million 9.45 Million 10.93 Million 8.72 Million 7.73 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 2.00 -44.85 Million - 1.00 -
Other Liabilities 1.00 1.00 1.00 1.00 - 1.00
Total Equity 2.14 Billion 1.46 Billion 1.25 Billion 1.12 Billion 645.18 Million 597.59 Million
Stock Holders Equity 2.14 Billion 1.46 Billion 1.25 Billion 1.12 Billion 645.18 Million 597.59 Million
Common Stock 593.06 Million 401.86 Million 287.04 Million 239.2 Million 160 Million 160 Million
Retained Earnings 767.15 Million 588.86 Million 408.27 Million 294.14 Million 227.8 Million 185.85 Million
Accumulated other comprehensive income 103.89 Million 75.68 Million 49.95 Million 36.14 Million 28.72 Million 23.1 Million
Common Stock Equity 2.14 Billion 1.46 Billion 1.25 Billion 1.12 Billion 645.18 Million 597.59 Million
Capital Lease Obligation 2.03 Million - - - - -
Total Investments 67.36 Million 50.14 Million 32.64 Million 13.07 Million 542.45 Thousand 857.79 Thousand
Total Debt 412.92 Million 242.02 Million 109.93 Million 41.04 Million 44.95 Million 72 Million
Net Debt -711.3 Million -366.83 Million -454.62 Million -698.06 Million -296.58 Million -206.03 Million

Balance Sheet Charts